Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era.

Savoie ML, Bence-Bruckler I, Huebsch LB, Lalancette M, Hillis C, Walker I, Lipton JH, Forrest DL, Kim DDH.

Leuk Res. 2018 Oct;73:67-75. doi: 10.1016/j.leukres.2018.08.021. Epub 2018 Sep 5.

PMID:
30227318
2.

Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation.

Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K.

J Gastrointest Cancer. 2018 Jul 30. doi: 10.1007/s12029-018-0147-7. [Epub ahead of print]

PMID:
30058032
3.

Short- and long-latency afferent inhibition; uses, mechanisms and influencing factors.

Turco CV, El-Sayes J, Savoie MJ, Fassett HJ, Locke MB, Nelson AJ.

Brain Stimul. 2018 Jan - Feb;11(1):59-74. doi: 10.1016/j.brs.2017.09.009. Epub 2017 Sep 20. Review.

PMID:
28964754
4.

Quasi-experimental evaluation of a multifaceted intervention to improve quality of end-of-life care and quality of dying for patients with advanced dementia in long-term care institutions.

Verreault R, Arcand M, Misson L, Durand PJ, Kroger E, Aubin M, Savoie M, Hadjistavropoulos T, Kaasalainen S, Bédard A, Grégoire A, Carmichael PH.

Palliat Med. 2018 Mar;32(3):613-621. doi: 10.1177/0269216317719588. Epub 2017 Jul 21.

PMID:
28731379
5.

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

Liu HD, Ahn KW, Hu ZH, Hamadani M, Nishihori T, Wirk B, Beitinjaneh A, Rizzieri D, Grunwald MR, Sabloff M, Olsson RF, Bajel A, Bredeson C, Daly A, Inamoto Y, Majhail N, Saad A, Gupta V, Gerds A, Malone A, Tallman M, Reshef R, Marks DI, Copelan E, Gergis U, Savoie ML, Ustun C, Litzow MR, Cahn JY, Kindwall-Keller T, Akpek G, Savani BN, Aljurf M, Rowe JM, Wiernik PH, Hsu JW, Cortes J, Kalaycio M, Maziarz R, Sobecks R, Popat U, Alyea E, Saber W.

Biol Blood Marrow Transplant. 2017 May;23(5):767-775. doi: 10.1016/j.bbmt.2017.01.078. Epub 2017 Jan 20.

6.

Increasing the Frequency and Timeliness of Pain Assessment and Management in Long-Term Care: Knowledge Transfer and Sustained Implementation.

Hadjistavropoulos T, Williams J, Kaasalainen S, Hunter PV, Savoie ML, Wickson-Griffiths A.

Pain Res Manag. 2016;2016:6493463. doi: 10.1155/2016/6493463. Epub 2016 Mar 3.

7.

Perovskite Photodetectors Operating in Both Narrowband and Broadband Regimes.

Saidaminov MI, Haque MA, Savoie M, Abdelhady AL, Cho N, Dursun I, Buttner U, Alarousu E, Wu T, Bakr OM.

Adv Mater. 2016 Oct;28(37):8144-8149. doi: 10.1002/adma.201601235. Epub 2016 Jul 7.

PMID:
27390113
8.

Impact of Donor and Recipient Cytomegalovirus Serostatus on Outcomes of Antithymocyte Globulin-Conditioned Hematopoietic Cell Transplantation.

Kalra A, Williamson T, Daly A, Savoie ML, Stewart DA, Khan F, Storek J.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1654-1663. doi: 10.1016/j.bbmt.2016.05.020. Epub 2016 May 28.

9.

Assessment of inattention in the context of delirium screening: one size does not fit all!

Voyer P, Champoux N, Desrosiers J, Landreville P, Monette J, Savoie M, Carmichael PH, Richard S, Bédard A.

Int Psychogeriatr. 2016 Aug;28(8):1293-301. doi: 10.1017/S1041610216000533. Epub 2016 Mar 23.

PMID:
27004924
10.

Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.

Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2136-42. doi: 10.2215/CJN.03640415. Epub 2015 Nov 17.

11.

Sleep Duration and Academic Performance Among Student Pharmacists.

Zeek ML, Savoie MJ, Song M, Kennemur LM, Qian J, Jungnickel PW, Westrick SC.

Am J Pharm Educ. 2015 Jun 25;79(5):63. doi: 10.5688/ajpe79563.

12.

RADAR: A Measure of the Sixth Vital Sign?

Voyer P, Champoux N, Desrosiers J, Landreville P, McCusker J, Monette J, Savoie M, Carmichael PH, Richard H, Richard S.

Clin Nurs Res. 2016 Feb;25(1):9-29. doi: 10.1177/1054773815603346. Epub 2015 Sep 2.

PMID:
26337503
13.

Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.

Awissi DK, Beauchamp A, Hébert E, Lavigne V, Munoz DL, Lebrun G, Savoie M, Fagnan M, Amyot J, Tétreault N, Robitaille R, Varin F, Lavallée C, Pichette V, Leblanc M.

Pharmacotherapy. 2015 Jun;35(6):600-7. doi: 10.1002/phar.1604.

PMID:
26095008
14.

Recognizing acute delirium as part of your routine [RADAR]: a validation study.

Voyer P, Champoux N, Desrosiers J, Landreville P, McCusker J, Monette J, Savoie M, Richard S, Carmichael PH.

BMC Nurs. 2015 Apr 1;14:19. doi: 10.1186/s12912-015-0070-1. eCollection 2015.

15.

Intention to change nutrition-related behaviors in adult participants of a Supplemental Nutrition Assistance Program-Education.

Savoie MR, Mispireta M, Rankin LL, Neill K, LeBlanc H, Christofferson D.

J Nutr Educ Behav. 2015 Jan-Feb;47(1):81-5. doi: 10.1016/j.jneb.2014.08.009. Epub 2014 Sep 27.

PMID:
25270972
16.

[Defending the promotion of clinical judgement].

Voyer P, Mercier J, Roy S, Claveau D, Kasprzak L, Lépine H, Mignault J, Rey S, Fortin MC, Desrochers A, Wilchesky M, Tremblay L, Savoie M, Roy O, Morin D.

Perspect Infirm. 2014 Sep-Oct;11(4):27-32. French. No abstract available.

PMID:
25269236
17.

Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia.

Anderson KR, Chambers CR, Lam N, Yau PS, Cusano F, Savoie ML, Sheikh N.

J Oncol Pharm Pract. 2015 Feb;21(1):19-25. doi: 10.1177/1078155213520261. Epub 2014 Feb 6.

PMID:
24503243
18.

Deamination intensity profiling of human APOBEC3 protein activity along the near full-length genomes of HIV-1 and MoMLV by HyperHRM analysis.

Bélanger K, Savoie M, Aydin H, Renner TM, Montazeri Z, Langlois MA.

Virology. 2014 Jan 5;448:168-75. doi: 10.1016/j.virol.2013.10.008. Epub 2013 Oct 25.

19.

Effect of an interdisciplinary educational program on antipsychotic prescribing among residents with dementia in two long-term care centers.

Monette J, Monette M, Sourial N, Vandal AC, Wolfson C, Champoux N, Fletcher J, Savoie ML.

J Appl Gerontol. 2013 Oct;32(7):833-54. doi: 10.1177/0733464812440042. Epub 2012 Jun 4.

PMID:
25474800
20.

Establishing a target exposure for once-daily intravenous busulfan given with fludarabine and thymoglobulin before allogeneic transplantation.

Russell JA, Kangarloo SB, Williamson T, Chaudhry MA, Savoie ML, Turner AR, Larratt L, Storek J, Bahlis NJ, Shafey M, Brown CB, Yang M, Geddes M, Zacarias N, Yue P, Duggan P, Stewart DA, Daly A.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1381-6. doi: 10.1016/j.bbmt.2013.07.002. Epub 2013 Jul 17. Erratum in: Biol Blood Marrow Transplant. 2014 Feb;20(2):290.

21.

Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses.

Bélanger K, Savoie M, Rosales Gerpe MC, Couture JF, Langlois MA.

Nucleic Acids Res. 2013 Aug;41(15):7438-52. doi: 10.1093/nar/gkt527. Epub 2013 Jun 12.

22.

Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research.

Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, Hale GA, Lazarus HM, Litzow MR, Maharaj D, Marks DI, Martino R, Maziarz RT, Rowe JM, Rowlings PA, Savani BN, Savoie ML, Szer J, Waller EK, Wiernik PH, Weisdorf DJ.

Biol Blood Marrow Transplant. 2013 Jul;19(7):1102-8. doi: 10.1016/j.bbmt.2013.04.022. Epub 2013 Apr 28.

23.

[Pain in the elderly].

Misson L, Savoie ML, Verreault R.

Perspect Infirm. 2012 Nov-Dec;9(6):39-44. French. No abstract available.

PMID:
23234227
24.

[Pain and dementia in long term care].

Savoie ML, Misson L, Verreault R.

Perspect Infirm. 2012 Nov-Dec;9(6):36-8. French. No abstract available.

PMID:
23234226
25.

Educational needs of health care providers working in long-term care facilities with regard to pain management.

Tousignant-Laflamme Y, Tousignant M, Lussier D, Lebel P, Savoie M, Lalonde L, Choinière M.

Pain Res Manag. 2012 Sep-Oct;17(5):341-6.

26.

Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbidities.

Daly A, Savoie ML, Geddes M, Chaudhry A, Stewart D, Duggan P, Bahlis N, Storek J, Brown C, Shafey M, Turner AR, Russell J.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1921-6. doi: 10.1016/j.bbmt.2012.07.017. Epub 2012 Jul 27.

27.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, Di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ.

Biol Blood Marrow Transplant. 2012 Feb;18(2):280-8. doi: 10.1016/j.bbmt.2011.07.024. Epub 2011 Jul 31.

28.

Development and validation of a test dose strategy for once-daily i.v. busulfan: importance of fixed infusion rate dosing.

Kangarloo SB, Naveed F, Ng ES, Chaudhry MA, Wu J, Bahlis NJ, Brown CB, Daly A, Duggan P, Geddes M, Quinlan D, Savoie ML, Shafey M, Stewart DA, Storek J, Yang M, Zacarias N, Yue P, Magliocco AM, Russell JA.

Biol Blood Marrow Transplant. 2012 Feb;18(2):295-301. doi: 10.1016/j.bbmt.2011.07.015. Epub 2011 Jul 27.

29.

Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty.

Lachance K, Savoie M, Bernard M, Rochon S, Fafard J, Robitaille R, Vendittoli PA, Lévesque S, de Denus S.

Ann Pharmacother. 2011 Jun;45(6):764-70. doi: 10.1345/aph.1P757. Epub 2011 Jun 10.

PMID:
21666087
30.

Integrating microsatellite and pedigree analyses to facilitate the captive management of the endangered Mississippi sandhill crane (Grus canadensis pulla).

Henkel JR, Jones KL, Hereford SG, Savoie ML, Leibo SP, Howard JJ.

Zoo Biol. 2012 May-Jun;31(3):322-35. doi: 10.1002/zoo.20399. Epub 2011 May 20.

PMID:
21604289
31.

Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG.

El Kourashy S, Williamson T, Chaudhry MA, Savoie ML, Turner AR, Larratt L, Storek J, Bahlis NJ, Brown CB, Yang M, Quinlan D, Geddes M, Zacarias N, Daly A, Duggan P, Stewart DA, Russell JA.

Bone Marrow Transplant. 2011 Aug;46(8):1077-83. doi: 10.1038/bmt.2010.257. Epub 2010 Nov 8.

PMID:
21057555
32.

The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia.

Russell JA, Irish W, Balogh A, Chaudhry MA, Savoie ML, Turner AR, Larratt L, Storek J, Bahlis NJ, Brown CB, Quinlan D, Geddes M, Zacarias N, Daly A, Duggan P, Stewart DA.

Biol Blood Marrow Transplant. 2010 Apr;16(4):509-14. doi: 10.1016/j.bbmt.2009.11.017. Epub 2009 Dec 3.

33.

Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.

Weiss K, Boisvert A, Chagnon M, Duchesne C, Habash S, Lepage Y, Letourneau J, Raty J, Savoie M.

Infect Control Hosp Epidemiol. 2009 Feb;30(2):156-62. doi: 10.1086/593955.

PMID:
19125681
34.

Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease.

Russell JA, Duan Q, Chaudhry MA, Savoie ML, Balogh A, Turner AR, Larratt L, Storek J, Bahlis NJ, Brown CB, Quinlan D, Geddes M, Zacarias N, Daly A, Duggan P, Stewart DA.

Biol Blood Marrow Transplant. 2008 Aug;14(8):888-95. doi: 10.1016/j.bbmt.2008.05.010.

35.

Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.

Labbé AC, Poirier L, Maccannell D, Louie T, Savoie M, Béliveau C, Laverdière M, Pépin J.

Antimicrob Agents Chemother. 2008 Sep;52(9):3180-7. doi: 10.1128/AAC.00146-08. Epub 2008 Jun 23.

36.

[Validity 'and Utilities' clinic of a grid observation (PACSLAC-F) to evaluate the pain in seniors with dementia's living in the Long-Term Care ].

Aubin M, Verreault R, Savoie M, LeMay S, Hadjistavropoulos T, Fillion L, Beaulieu M, Viens C, Bergeron R, Vézina L, Misson L, Fuchs-Lacelle S.

Can J Aging. 2008 Spring;27(1):45-55. doi: 10.3138/cja.27.1.045. French.

PMID:
18492636
37.

Contemporary disease management in Quebec.

Gogovor A, Savoie M, Moride Y, Krelenbaum M, Montague T.

Healthc Q. 2008;11(1):30-7. Review.

PMID:
18326378
38.

High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen.

Geddes M, Kangarloo SB, Naveed F, Quinlan D, Chaudhry MA, Stewart D, Savoie ML, Bahlis NJ, Brown C, Storek J, Andersson BS, Russell JA.

Biol Blood Marrow Transplant. 2008 Feb;14(2):220-8. doi: 10.1016/j.bbmt.2007.10.028.

39.
40.
41.

Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004.

Weiss K, Bergeron L, Bernatchez H, Goyette M, Savoie M, Thirion D.

Int J Antimicrob Agents. 2007 Oct;30(4):309-14. Epub 2007 Jul 20.

PMID:
17644347
42.

Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.

Russell JA, Savoie ML, Balogh A, Turner AR, Larratt L, Chaudhry MA, Storek J, Bahlis NJ, Brown CB, Quinlan D, Geddes M, Stewart DA.

Biol Blood Marrow Transplant. 2007 Jul;13(7):814-21. Epub 2007 Apr 23.

43.

Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinib.

Clark GM, Zborowski DM, Culbertson JL, Whitehead M, Savoie M, Seymour L, Shepherd FA.

J Thorac Oncol. 2006 Oct;1(8):837-46.

44.

Governing therapy choices: power/knowledge in the treatment of progressive renal failure.

Holmes D, Perron AM, Savoie M.

Philos Ethics Humanit Med. 2006 Dec 4;1:12.

45.

Shifting to outpatient management of acute myeloid leukemia: a prospective experience.

Savoie ML, Nevil TJ, Song KW, Forrest DL, Hogge DE, Nantel SH, Shepherd JD, Smith CA, Sutherland HJ, Toze CL, Lavoie JC.

Ann Oncol. 2006 May;17(5):763-8. Epub 2006 Feb 23.

PMID:
16497826
46.

Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia.

Makowsky MJ, Warkentin DI, Savoie ML.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1365-6. Epub 2005 Jun 14. No abstract available.

PMID:
15956243
47.

A pelvic drain may be avoided after radical retropubic prostatectomy.

Savoie M, Soloway MS, Kim SS, Manoharan M.

J Urol. 2003 Jul;170(1):112-4.

PMID:
12796659
48.
49.

Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion.

Sofer M, Savoie M, Kim SS, Civantos F, Soloway MS.

J Urol. 2003 Jan;169(1):153-6.

PMID:
12478125
50.

Management of renal cell carcinoma with level III thrombus in the inferior vena cava.

Ciancio G, Vaidya A, Savoie M, Soloway M.

J Urol. 2002 Oct;168(4 Pt 1):1374-7.

PMID:
12352396

Supplemental Content

Loading ...
Support Center